コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 matopoietic maintenance factor expression in bone marrow macrophages.
2 ) sufficient for a locus control function in bone marrow macrophages.
3 fibroblasts, primary embryo fibroblasts, and bone marrow macrophages.
4 ive in C. elegans intestinal cells and mouse bone marrow macrophages.
5 llino 2 in human 293-IL-1R cells and primary bone marrow macrophages.
6 bone marrow, where they are phagocytosed by bone marrow macrophages.
7 phosphorylation and STAT1 ubiquitination in bone marrow macrophages.
8 MSP-1 to inhibit nitric oxide production in bone marrow macrophages.
9 ke was examined in osteoclasts prepared from bone marrow macrophages.
10 ve stress but did not impair growth in mouse bone marrow macrophages.
11 rophage colony-stimulating factor (M-CSF) in bone marrow macrophages.
14 ofiling of isogenic wild-type and cebpb(-/-) bone marrow macrophages and identified a number of IFN-g
15 ication was confirmed in vitro using primary bone marrow macrophages and in vivo for peritoneal macro
18 osine receptor (A2bAR) is highly abundant in bone marrow macrophages and vascular smooth muscle cells
19 crosis factor alpha (TNF-alpha) release from bone marrow macrophages, and both were shown to activate
20 tify discrete DNA-binding factors in primary bone marrow macrophages as candidate transcriptional reg
23 of NF-kappaB ligand (RANKL)-activated murine bone marrow macrophage (BMM) cultures revealed unique up
24 egulated the development of F4/80(+)VCAM1(+) bone marrow macrophages (BMM) and that Spic expression i
25 , we compared the CSF-1 responses of primary bone marrow macrophages (BMM) from wild-type and SHP-1-d
29 noparticles (NP, nanoART) loaded into murine bone marrow macrophages (BMM, IDV-NP-BMM) after ex vivo
30 okines is suppressed in mice with DIO and in bone marrow macrophages (BMMPhi) from mice with DIO expo
31 une evasion genes function in H-2(b) primary bone marrow macrophages (BMMphi) in the same way that th
32 associated peptide antigen by differentiated bone marrow macrophages (BMMphis) to a T cell hybridoma
35 Consistent with these observations, primary bone marrow macrophages (BMMs) derived from S100A4(-/-)
37 Myr)-Akt or a dominant-negative CAAX-Akt and bone marrow macrophages (BMMs) from wild-type and transg
38 ear proteins from RAW264.7 cells and primary bone marrow macrophages (BMMs) in an electrophoretic mob
43 decreases upon stimulation of wild type (WT) bone marrow macrophages (BMMs) with RANKL, TAK1 deficien
44 hat implant particles induce c-src in murine bone marrow macrophages (BMMs), a protein specifically e
45 we find TNF induction of NF-kappaB in murine bone marrow macrophages (BMMs), is mediated, by c-Src, i
46 id phosphatase, and carbonic anhydrase II in bone marrow macrophages (BMMs), RANKL renders these oste
47 in cultured mouse bone marrow cells (BMCs), bone marrow macrophages (BMMs), spleen cells, and RAW264
48 inhibits formation of osteoclasts (OCs) from bone marrow macrophages (BMMs), we examined the capacity
49 ntrast to other cell types, IkappaBalpha, in bone marrow macrophages (BMMs), which are osteoclast pre
52 socs3, and il10 expression in infected mouse bone marrow macrophages but did correlate with enhanced
53 urine alveolar macrophages as well as murine bone marrow macrophages, but not alveolar epithelial cel
54 how that expression of AnxA1 is required for bone marrow macrophages, but not peritoneal macrophages,
56 umber of osteoclasts derived from MAGP1Delta bone marrow macrophage cells is increased relative to th
57 utant, we further show that in an osteoblast/bone marrow macrophage co-culture system, immobilization
61 Chromatin immunoprecipitation experiments in bone marrow macrophages confirmed that EWS, but not FUS/
63 y to support osteoclastogenesis in wild-type bone marrow macrophages, demonstrating that CD47-induced
65 for effector translocation were discerned in bone marrow macrophages derived from C57BL/6 mice, which
67 ophages, LPS-induced events were compared in bone marrow macrophages derived from SHIP(+/+) and SHIP(
71 peripheral blood cells and the percentage of bone marrow macrophages did not differ between VDR KO an
73 ern analysis of rat glioma C6 cells or mouse bone marrow macrophages exposed to crosslinking reagents
74 e trait loci mapping of lysosome function in bone marrow macrophages from an AKR/J x DBA/2J strain in
76 expression of the M-CSFR in M-CSF-dependent bone marrow macrophages from Dicer-deficient mice rescue
79 0 synthesis and inhibited IL-12 synthesis by bone marrow macrophages from normal, but not gamma-chain
80 n comparable experiments employing activated bone marrow macrophages from wild-type and NO synthase 2
81 e II strain to enhance the capacity of mouse bone marrow macrophages (from primary cultures) and huma
83 Similar observations were made with murine bone marrow macrophages infected ex vivo: growth of the
84 rovar Typhimurium-infected BALB/c mice lysed bone marrow macrophages infected with S. enterica serova
85 PKD activity is dispensable for induction of bone marrow macrophages into tartrate-resistant acid pho
86 tilized to monitor differential migration of bone marrow macrophages into viable and apoptotic MASIs
87 .01, 0.1, and 1.0) were incubated with mouse bone marrow macrophages isolated from C57BL/6J mice and
88 A sequencing to profile the transcriptome of bone marrow macrophages isolated from diabetic db/db mic
91 L. monocytogenes-infected B6.Tla(a)-derived bone marrow macrophages (Kb Qa-1a) are not lysed by BALB
92 n mediating RANKL-induced signaling in mouse bone marrow macrophages, known as osteoclast precursors.
94 ell compartment and enhances the response of bone marrow macrophages, monocytes, and splenocytes to s
95 oclast (OC) differentiation in cocultures of bone marrow macrophages/monocytes (BMMs) and OBs after t
97 RAW264.7 cells expressing SHP-1(C453S), the bone marrow macrophages of Me(v)/Me(v) mice generated mu
100 s in the nuclei of osteoclasts but not their bone marrow macrophage precursors and that osteoclast in
101 ion in the capacity to form osteoclasts from bone marrow macrophage precursors in vitro in response t
102 eading to failure of the PLCgamma2-deficient bone marrow macrophage precursors to differentiate into
106 L-13Ralpha2-deficient mice display increased bone marrow macrophage progenitor frequency and decrease
109 eoblast and chondrocyte lineages, as well as bone marrow macrophages, showed intense beta-gal histo-
110 riptional program, which was also present in bone marrow macrophages sorted from patients with sHLH.
112 that the uptake of apoptotic neutrophils by bone marrow macrophages stimulates their production of G
117 sequences and did not affect the capacity of bone marrow macrophages to form osteoclasts in vitro In
118 othesis, we found that C57BL/6 mouse-derived bone marrow macrophages treated with exosomes released f
119 eoclasts formed by differentiating CD47(-/-) bone marrow macrophages was decreased, high doses of RAN
120 d (RifK) M. tuberculosis in activated murine bone marrow macrophages was examined by using an I-A(b)-
124 studied gene expression in RNAs from BALB/c bone marrow macrophages with and without Leishmania chag
125 te, increased after 2-3 days of treatment of bone marrow macrophages with M-CSF and RANKL, correspond
126 paired for intracellular growth within mouse bone marrow macrophages, with the defect absolute in tri